Adverse events may or may not be caused by the treatments in the study. A lot
of research is needed to know whether a treatment causes an adverse event.
Ceralasertib by Ceralasertib and
itself acalabrutinib
(out of 8 participants) (out of 3 participants)
How many participants had
100% (8) 100% (3)
adverse events?
How many participants had
75.0% (6) 33.3% (1)
serious adverse events?
How many participants
stopped taking study
none none
treatment due to adverse
events?
The most common serious adverse events that happened in more than
1 participant were:
X Low red blood cell levels
X Low levels of platelets in the blood, which are cells that help blood to clot
The most common adverse events were:
X Low red blood cell levels
X Low levels of platelets in the blood, which are cells that help blood to clot
X Cough
X Diarrhea
X Fatigue
X Nausea
X Upper respiratory tract infection
10 | Clinical Study Results